Detalles de la búsqueda
1.
BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Int J Mol Sci
; 22(19)2021 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638998
Resultados
1 -
1
de 1
1
Próxima >
>>